For individuals living with sickle cell disease (SCD), the transition from pediatric to adult care can be one of the most ...

Major is one of the first pediatric patients in Florida to receive gene therapy for sickle cell disease since the FDA ...

Motixafortide alone and in combination with natalizumab (VLA-4 inhibitor) led to robust hematopoietic stem cell (HSC) ...

Most people with sickle cell disease who undergo allogeneic hematopoietic cell transplantation achieve favorable long-term ...

Caden Major was born with sickle cell disease – an inherited blood disorder affecting red blood cells. Now at 19 years old, ...

Preliminary results from two trials of the gene therapy exagamglogene autotemcel (exa-cel) suggest the therapy offers an ...

“To provide menstruating patients with sickle cell disease the best care, primary care physicians, gynecologists, and ...

Less than a third of ED visits for acute sickle cell disease pain were guideline-adherent for the timely administration of ...

Patients who underwent hematopoietic cell transplantation for sickle cell disease saw high rates of survival without disease ...

A higher dose of the experimental pill for sickle cell disease showed more promise, Fulcrum said at the American Society of ...

Guideline adherence for opioid pain medications was found to be suboptimal among patients with sickle cell disease pain in the ED.

For years, my family struggled to understand the constant, mysterious pain my younger sister and I endured. Her cries were so frequent that she earned the nickname “Holly” because she was always ...